20:45 , Feb 10, 2017 |  BC Week In Review  |  Clinical News

THC:CBD: Ph II data

Top-line data from 21 patients with recurrent GBM in the double-blind second part of a European Phase II trial showed that THC:CBD plus temozolomide led to a 1-year OS rate, a secondary endpoint, of 83%...
18:53 , Feb 7, 2017 |  BC Extra  |  Clinical News

GW reports survival data in Phase II GBM study

GW Pharmaceuticals plc (NASDAQ:GWPH) said data from a Phase II trial showed that THC:CBD (GW42002:GW42003) significantly improved one-year overall survival vs. placebo as an add-on therapy to treat glioblastoma multiforme. Among the study's 21 patients,...
07:00 , Jul 25, 2016 |  BC Week In Review  |  Financial News

GW Pharma financial update

GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH), Salisbury, U.K.   Business: Neurology, Endocrine/Metabolic, Cancer   Date announced: 2016-07-18   Note: GW Pharmaceuticals raised $37.8 million through the sale of 420,000 ADSs at $90 to cover the overallotment...
07:00 , Jul 18, 2016 |  BC Week In Review  |  Financial News

GW Pharma completes follow-on

GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH), Salisbury, U.K.   Business: Neurology, Endocrine/Metabolic, Cancer   Date completed: 2016-07-12   Type: Follow-on   Raised: $252 million   Shares: 2.8 million   Price: $90   Shares after offering: 24.7...
08:00 , Nov 9, 2015 |  BC Week In Review  |  Clinical News

THC:CBD: Phase I started

MMJ PhytoTech Ltd. (ASX:MMJ), Nedlands, Australia   Product: THC:CBD   Business: Autoimmune   Molecular target: Cannabinoid receptors   Description: Oral pro-nanolipospheres containing tetrahydrocannabinol (THC) and cannabidiol (CBD)   Indication: Treat pain and spasticity in multiple...
07:00 , May 25, 2015 |  BC Week In Review  |  Financial News

GW Pharma financial update

GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH), Salisbury, U.K.   Business: Neurology, Autoimmune   Date announced: 2015-05-15   Note: GW Pharmaceuticals raised $26.9 million through the sale of 240,000 ADSs at $112 to cover the overallotment from...
07:00 , May 4, 2015 |  BC Week In Review  |  Financial News

GW Pharma completes follow-on

GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH), Salisbury, U.K.   Business: Neurology, Autoimmune   Date completed: 2015-04-28   Type: Follow-on   Raised: $179.2 million   Shares: 1.6 million   Price: $112   Shares after offering: 21.4 million...
07:00 , Jul 14, 2014 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes...
07:00 , Jun 30, 2014 |  BC Week In Review  |  Financial News

GW Pharma financial update

GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH), Salisbury, U.K.   Business: Neurology, Autoimmune   Date announced:2014-06-24   Note: GW raised $22.1 million through the sale of 255,000 ADSs at $86.83 to cover the overallotment from its June...
07:00 , Jun 23, 2014 |  BC Week In Review  |  Financial News

GW Pharma completes follow-on

GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH), Salisbury, U.K.   Business: Neurology, Autoimmune   Date completed: 2014-06-18   Type: Follow-on   Raised: $104.2 million   Shares: 1.2 million   Price: $86.83   Shares after offering: 11.1 million...